Crozier T A, Müller J E, Quittkat D, Sydow M, Wuttke W, Kettler D
Zentrum Anaesthesiologie, Rettungs- und Intensivmedizin, Frauenheilkunde der Georg-August-Universität, Göttingen.
Anaesthesist. 1994 Sep;43(9):594-604. doi: 10.1007/s001010050098.
Total intravenous anaesthesia (TIVA) using a combination of a hypnotic and an analgesic agent is gaining increasing popularity as an alternative to balanced anaesthesia with volatile anaesthetics for abdominal surgery. Among the required characteristics of the drugs used in this technique are a good correlation between dose, plasma concentrations, and effect as well as rapid elimination from the circulation, allowing close control of anaesthetic depth. Two hypnotic drugs with similar pharmacokinetic and pharmacodynamic profiles are propofol and methohexitone, both of which can be employed as a component of a TIVA technique. Two TIVA combinations utilising either of these drugs with alfentanil were tested against isoflurane-nitrous oxide in a balanced regimen. METHODS. Twenty-seven healthy women undergoing hysterectomy for non-malignant diseases participated in the study after having given written consent. They were randomly allocated to receive either isoflurane (Iso), methohexital-alfentanil (M-A), or propofol-alfentanil (P-A). Blood samples for determination of cortisol, prolactin, catecholamines, glucose, lactate, non-esterified fatty acids, and pharmacon concentrations were drawn repeatedly from before induction until 360 min after surgery. Anaesthesia was induced in group Iso with fentanyl 0.1 mg and M 1.5 mg.kg-1 and maintained with Iso-N2O. In the TIVA groups M or P was given in a two-step infusion to load peripheral compartments and then maintain plasma concentrations within the hypnotic range. A was given as a continuous infusion in an identical dose (0.1 mg.kg-1 initial, 0.125 mg.kg-1.h-1 maintenance) in both groups. If signs of insufficient depth of anaesthesia occurred (heart rate or systolic blood pressure > 25% above baseline), then first A (0.5-1 mg), and if that was ineffective, then 50 mg hypnotic was administered. The A infusion was stopped 30 min before the end of surgery, and Iso or the hypnotic was stopped at skin closure. Recovery time was the time until the patients were able to give their birth date after stopping the Iso or hypnotic. RESULTS. The three groups were comparable with regard to age, weight, and duration of surgery. The total doses of M and P were 1,357 +/- 125 mg (mean +/- SEM) and 1,315 +/- 121 mg, respectively, and the total A doses were 20.7 +/- 2.5 mg (M-A) and 23.4 +/- 3.5 (P-A). The peak plasma concentrations were P 10.6 +/- 1.5 micrograms.ml-1 and M 12.4 +/- 2.6 micrograms.ml-1. At the end of surgery the P concentrations were in the projected range while those of M were somewhat lower than expected (P 3.7 +/- 0.4 microgram.ml-1; M 3.5 +/- 0.6 microgram.ml-1). Three patients each in the P-A and M-A groups required supplementary A injections. Five patients in the P-A group required additional bolus injections of the hypnotic as compared to 2 in the M-A group. The median recovery times were Iso 15 min, M-A 50 min, and P-A 25 min (P < 0.05). The incidence of shivering was Iso 3/9, M-A 5/9, and P-A 0/9 (P < 0.05); vomiting occurred with equal frequency in all groups (Iso 33%, M-A 33%, P-A 22%). The patients were somewhat more restless in group M-A. Systolic blood pressure dropped in a similar manner in all groups after induction of anaesthesia (Iso -31%, M-A -37%, P-A -36%) but recovered during surgery. The intraoperative response of cortisol (Iso + 216%, M-A +92%, P-A +43%) and catecholamines (noradrenaline Iso +56%, M-A +30%, P-A -21%) was lower in the TIVA groups, whereas prolactin increased after induction in all groups. Plasma concentrations of glucose, lactate, and fatty acids were lower in the TIVA groups than in the Iso group intraoperatively, but increased to comparable postoperative levels. CONCLUSIONS. Both TIVA regimens are acceptable alternatives to balanced anaesthesia with Iso N2O. (ABSTRACT TRUNCATED)
使用催眠药和镇痛药联合的全静脉麻醉(TIVA)作为腹部手术挥发性麻醉药平衡麻醉的替代方法正越来越受欢迎。该技术中使用的药物所需的特性包括剂量、血浆浓度和效应之间具有良好的相关性,以及能迅速从循环中消除,从而便于密切控制麻醉深度。丙泊酚和甲己炔巴比妥是两种具有相似药代动力学和药效学特征的催眠药,二者均可作为TIVA技术的组成部分。将使用这两种药物之一与阿芬太尼组成的两种TIVA组合,与异氟烷 - 氧化亚氮平衡麻醉方案进行对比测试。方法:27名因非恶性疾病接受子宫切除术的健康女性在签署书面同意书后参与了本研究。她们被随机分配接受异氟烷(Iso)、甲己炔巴比妥 - 阿芬太尼(M - A)或丙泊酚 - 阿芬太尼(P - A)麻醉。从诱导前直至术后360分钟,反复采集血样以测定皮质醇、催乳素、儿茶酚胺、葡萄糖、乳酸、非酯化脂肪酸和药物浓度。Iso组用0.1mg芬太尼和1.5mg·kg-1的M诱导麻醉,并用Iso - N2O维持。在TIVA组中,M或P采用两步输注给药以充盈外周室,然后将血浆浓度维持在催眠范围内。两组均以相同剂量(初始0.1mg·kg-1,维持0.125mg·kg-1·h-1)持续输注A。如果出现麻醉深度不足的体征(心率或收缩压高于基线25%以上),则首先给予A(0.5 - 1mg),如果无效,则给予50mg催眠药。手术结束前30分钟停止输注A,皮肤缝合时停止使用Iso或催眠药。恢复时间是指停止使用Iso或催眠药后患者能够说出出生日期的时间。结果:三组在年龄、体重和手术持续时间方面具有可比性。M和P的总剂量分别为1357±125mg(均值±标准误)和1315±121mg,A的总剂量分别为20.7±2.5mg(M - A)和23.4±3.5mg(P - A)。血浆峰值浓度分别为P 10.6±1.5μg·ml-1和M 12.4±2.6μg·ml-1。手术结束时,P的浓度在预计范围内,而M的浓度略低于预期(P 3.7±0.4μg·ml-1;M 3.5±0.6μg·ml-1)。P - A组和M - A组各有3例患者需要补充注射A。与M - A组的2例相比,P - A组有5例患者需要额外推注催眠药。中位恢复时间分别为Iso组15分钟,M - A组50分钟,P - A组25分钟(P < 0.05)。寒战发生率分别为Iso组3/9,M - A组5/9,P - A组0/9(P < 0.05);呕吐在所有组中发生率相同(Iso组33%,M - A组33%,P - A组22%)。M - A组患者略显烦躁不安。麻醉诱导后所有组的收缩压均以相似方式下降(Iso组 - 31%,M - A组 - 37%,P - A组 - 36%),但在手术过程中恢复。TIVA组术中皮质醇(Iso组 + 216%,M - A组 + 92%,P - A组 + 43%)和儿茶酚胺(去甲肾上腺素Iso组 + 56%,M - A组 + 30%,P - A组 - 21%)的反应较低,而所有组诱导后催乳素均升高。术中TIVA组的葡萄糖、乳酸和脂肪酸血浆浓度低于Iso组,但术后升高至相当水平。结论:两种TIVA方案都是Iso - N2O平衡麻醉的可接受替代方案。(摘要截选)